Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80021907: 18th Annual Lipid Disorders Training Center: Advanced Update

October 24, 2009
  • Download Brochure
  • Send to Colleague
  • Back to List
Click here for a text version of the brochure
Text version of brochure


18th Annual Lipid Disorders Training Center Brochure Cover Image


ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NURSING CREDIT
ANCC
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This 8.0 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing.
AANP (Pending Approval)
The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216.
Pharmacology hours are pending.
OTHER CREDIT
AAFP Pending
Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
American Academy of Physician Assistants (AAPA) AAPA accepts AMA Category 1 CME credit for the PRA from organizations accredited by ACCME.

Description:
The level of sophistication and knowledge of lipidology is increasing in all medical specialties. While many physicians and medical specialists are gaining the knowledge to prevent and/or manage common lipid disorders, there is a growing need for those with greater interest and knowledge in the field to share ground-breaking research and explore controversial areas that may stimulate more sophisticated clinical care. This activity expands upon the requisite knowledge of lipid disorders and analyzes more complex diagnosis and treatment methods to manage complicated cases.

Objectives:
After attending this activity, the participant should be able to:
• Apply the latest sophisticated information from genetic disorders to the diagnosis and treatment of dyslipidemias
• Identify patients who are more likely to have a defect in the SR-B1 receptor as the basis for their elevated HDL
• Utilize information from the vascular biological basis of atherosclerosis to understand the pathogenesis of dyslipidemia and CVD
• Add the determination of hsCRP to clinical evaluation and treatment of patients with normal LDL-C but elevated hsCRP
• Implement the latest advances in the dietary treatment of dyslipidemia
• Apply the latest information on non-traditional risk factors to the evaluation of patients with CVD but normolipidemia
• Employ the pathways in the brain and adipose tissue to treat the components of the cardiometabolic syndrome

Statement of Need:
The level of sophistication and knowledge of lipidology is increasing in all medical specialties. While many physicians and medical specialists are gaining the knowledge to prevent and/or manage common lipid disorders, there is a growing need for those with greater interest and knowledge in the field to share ground-breaking research and explore controversial areas that may stimulate more sophisticated clinical care.
This activity expands upon the requisite knowledge of lipid disorders and analyzes more complex diagnosis and treatment methods to manage complicated cases.

Talks

October 24, 2009  8:30 AM to 9:30 AM

Therapeutic Options for Modifying Cardiometabolic Risk Factors

Aronne, Louis
To learn about the pathophysiology of obesity and cardiometabolic risk as we understand it today; To learn about the multiple medical risks of obesity; To recognize which overweight patients needs treatment; To learn about the benefits of weight-centric management of diabetes; To learn about treatments for obesity and type 2 diabetes in development
October 24, 2009  9:30 AM to 10:30 AM

Vascular biology of the Pathophysiology of Atherosclerosis in the Arterial Wall

Chatterjee, Subroto
To understand the role of oxidized LDL and inflammation in atherosclerosis
October 24, 2009  10:45 AM to 11:45 AM

Relevance of Human Mutations in SRB1 for Human Disease

Rodriguez-Oquendo, Annabelle
October 24, 2009  11:45 AM to 12:45 PM

Plasma Lipoproteins: Genetic Influences and Clinical Implications

Kwiterovich, Peter
October 24, 2009  12:45 PM to 1:45 PM

Lunch with Novel Case Presentations

Kwiterovich, Peter
October 24, 2009  1:45 PM to 2:45 PM

Trans-Fatty Acids and Cardiovascular Disease

Franklin, Frank
To illustrate the structure and metabolism of trans fatty acids; To demonstrate the effects of trans fatty acids on lipoprotein metabolism and cardiovascular disease; To define the production and sources of trans fatty acids in the US food supply and the passage and efficacy of regulations to label foods and to ban trans fatty acids in commercial cooking
October 24, 2009  2:45 PM to 3:45 PM

Non-Traditional Risk Factors for Cardiovascular Disease

Margolis, Simeon
To recognize non-traditional risk factor for Cardiovascular Disease; To define the use of these risk factors in making management decisions
October 24, 2009  4:00 PM to 5:00 PM

Clinical Utility Markers of Inflammation

Mora, Samia
To differentiate between low to high and immediate risk cardiac patients using CRP levels; To discuss how therapies such as statins influence CRP levels

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Johns Hopkins Tilghman Room
Baltimore, MD
Directions

Registration Fee(s)

Physicians – $ 195.00
Res/Fel/AHP – $ 100.00

Target Audience(s)

This activity is intended for Cardiologsits, Internists, Family Practitioners, Pediatricians, Endocrinologists, Nurse Practitioners, Nurses, Dietitians and Pharmacists

Course Director

Peter Kwiterovich

Lodging

The Days Inn - Inner Harbor Hotel
100 Hopkins Place
Baltimore, MD 21201
Phone: 410 576-1000
Fax: 410 576-9437

Hotel Website

Days Inn - Inner Harbor

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET